Watsco to Host 2020 Third Quarter Earnings Call October 22, 2020
MIAMI, Oct. 12, 2020 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced today that it will host a conference call […]
Altimmune and UAB Announce Publication of Compelling Pre-clinical Data for AdCOVID™ Intranasal COVID-19 Vaccine Candidate
Comprehensive analysis shows AdCOVID uniquely stimulates three key immune components: serum neutralizing antibody, T cell responses, and mucosal immunity in […]
Cerecor Appoints Gilla Kaplan, Ph.D., to the Board of Directors
ROCKVILLE, Md. and CHESTERBROOK, Pa., Oct. 12, 2020 (GLOBE NEWSWIRE) — Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on […]
Newly Granted European Patent Protects VBL Therapeutics’ Anti-MOSPD2 Antibodies for Inflammation Until at least July 2036
TEL AVIV, Israel, Oct. 12, 2020 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT), today announced that the European Patent Office (EPO) […]
Morphic Announces Presentation of New Data Supporting Development of MORF-057 at UEG Week Virtual 2020
–Data validate physiologically relevant assay used in MORF-057 Phase 1 studies to measure receptor occupancy of α4β7integrin–-MORF-057, inhibitor of α4β7integrin, […]
BeyondSpring Forms Partnership Advisory Committee Comprised of Industry Veterans
NEW YORK, Oct. 12, 2020 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused […]
Greenlane Announces Worldwide Distribution Expansion of Marley Natural Accessories
BOCA RATON, Fla., Oct. 12, 2020 (GLOBE NEWSWIRE) — Greenlane Holdings, Inc. (“Greenlane” or “the Company”) (Nasdaq: GNLN), one of […]
DSP Group Ships 100 Millionth SmartVoice SoC
SAN JOSE, Calif., Oct. 12, 2020 (GLOBE NEWSWIRE) — DSP Group, Inc. (NASDAQ: DSPG), a leading global provider of wireless and voice-processing […]
Aileron Therapeutics Announces Proof-of-Concept Data for ALRN-6924 to be Featured in Late-Breaking Presentation at EORTC-NCI-AACR Annual Symposium
Aileron aims to create new paradigm of proactive prevention of chemotherapy-induced side effects to address significant unmet need among cancer […]
Ovid Therapeutics to Present at the Child Neurology Society/International Child Neurology Association (CNS/ICNA) Virtual Congress
Four abstracts from the OV101 (gaboxadol) clinical development program in Angelman Syndrome and Fragile X Syndrome to be presentedNEW YORK, […]
